Mycoplasma genitalium (Mgen) is a challenging sexually transmitted infection that often goes undetected due to its subtle nature and complex testing requirements. PCR (Polymerase Chain Reaction) testing is considered the most reliable method currently available to accurately detect this bacteria, as traditional testing methods frequently fail to identify this microscopic organism.
Our clinic provides confidential STI testing services. We do not provide GP services or dermatology consultations, but we can advise on appropriate next steps if further medical care is needed.
Mycoplasma genitalium PCR testing is essential because:
- Standard bacterial cultures cannot grow this organism
- Traditional testing methods lack sufficient sensitivity
- PCR detects genetic material with high accuracy
- Early detection prevents complications
- Many infections remain asymptomatic
Understanding Mycoplasma Genitalium
Mycoplasma genitalium is one of the smallest free-living organisms capable of causing infection in humans. This bacterium was only discovered in the 1980s and has since emerged as a significant cause of urethritis and other genital tract infections.
Unlike other bacteria, Mycoplasma genitalium lacks a cell wall, making it extremely difficult to detect through conventional testing methods. Its unique structure and slow growth characteristics mean that standard bacterial culture techniques, which work effectively for other STIs, are wholly inadequate for identifying Mgen infections.
The bacteria can cause symptoms in both men and women, though many infections remain completely asymptomatic, allowing the infection to persist undetected and potentially spread to sexual partners.
Why Traditional Testing Methods Fail
Standard bacterial culture methods, which successfully identify many other sexually transmitted infections, cannot reliably detect Mycoplasma genitalium. This limitation stems from several factors that make this organism particularly challenging to identify.
Traditional cultures require bacteria to grow in laboratory conditions, but Mycoplasma genitalium grows extremely slowly and requires highly specialised growth media that most laboratories do not routinely use. Even when appropriate conditions are provided, the bacteria often fails to grow in sufficient quantities for reliable detection.
Microscopy, another traditional diagnostic method, is equally ineffective due to the bacteria's exceptionally small size. Mycoplasma genitalium measures only 0.1-0.3 micrometers, making it virtually impossible to identify through standard microscopic examination techniques.
How PCR Testing Works for Mycoplasma Genitalium
PCR testing revolutionises Mycoplasma genitalium detection by identifying the bacteria's genetic material rather than attempting to grow or visualise the organism itself. This molecular approach provides unparalleled accuracy and sensitivity for detecting even small amounts of bacterial DNA.
During PCR testing, laboratory technicians extract genetic material from urine samples or genital swabs. The PCR process then amplifies specific DNA sequences unique to Mycoplasma genitalium, creating millions of copies that can be easily detected and measured.
This amplification process allows PCR testing to identify infections even when bacterial levels are extremely low, something that traditional culture methods cannot achieve. The technique can detect as few as 10-100 bacterial organisms per sample, providing exceptional sensitivity for early infection detection.
Results from Mycoplasma genitalium PCR testing are typically available within a few working days, offering rapid and reliable diagnosis when symptoms are present or exposure has occurred.
Symptoms That May Indicate Mycoplasma Genitalium
Mycoplasma genitalium infections can cause various symptoms, though many people experience no symptoms at all. When symptoms do occur, they often overlap with those caused by other sexually transmitted infections, making accurate testing essential for proper identification.
In men, common symptoms may include urethral discharge, burning sensation during urination, and discomfort or pain in the genital area. These symptoms can be mild and intermittent, sometimes leading people to dismiss them as temporary irritation.
Women may experience unusual vaginal discharge, pelvic pain, bleeding between periods, or discomfort during urination. However, symptoms in women are often subtle or absent entirely, which can delay diagnosis and treatment.
The non-specific nature of these symptoms means that appearance alone cannot confirm Mycoplasma genitalium infection, as similar symptoms may result from other STIs, urinary tract infections, or non-infectious causes.
When Mycoplasma Genitalium Testing May Be Appropriate
Testing for Mycoplasma genitalium may be sensible in several situations, particularly when there has been potential exposure or when symptoms suggest possible infection. Understanding when to consider testing helps ensure appropriate healthcare decisions.
Testing may be appropriate following unprotected sexual contact with new or multiple partners, as Mycoplasma genitalium spreads through sexual transmission. The bacteria can be transmitted through vaginal, anal, or oral sex, making any unprotected sexual activity a potential risk factor.
Persistent urogenital symptoms that do not resolve with standard treatments may indicate Mycoplasma genitalium infection. Because this organism requires specific antibiotics for effective treatment, infections may persist if initial treatment targets other bacteria without addressing Mgen.
Partners of individuals diagnosed with Mycoplasma genitalium should also consider testing, as the infection can spread between sexual partners even when symptoms are not present.
Comparing PCR to Other Testing Methods
The superiority of PCR testing for Mycoplasma genitalium becomes clear when compared to alternative testing approaches. Traditional bacterial culture, whilst effective for many other infections, has a success rate of less than 60% for detecting Mycoplasma genitalium.
Antigen detection tests, which identify bacterial proteins, also lack sufficient sensitivity for reliable Mycoplasma genitalium detection. These tests may miss up to 40% of infections, particularly during early stages when bacterial levels are lower.
PCR testing, by contrast, demonstrates sensitivity rates exceeding 95% and specificity rates above 98%, making it the preferred method for Mycoplasma genitalium diagnosis. This level of accuracy helps ensure that infections are more likely to be properly identified whilst minimising false positive results.
The reliability of PCR testing extends to different sample types, with both urine samples and genital swabs providing accurate results when processed using appropriate PCR techniques.
How STI Testing Works at Our Clinic
Our comprehensive STI testing process includes advanced PCR testing for Mycoplasma genitalium alongside screening for other sexually transmitted infections. Testing appointments are conducted in comfortable, private settings with complete confidentiality.
Sample collection is straightforward and can involve either a urine sample or a gentle swab, depending on the specific tests required. Our trained staff explain the collection process clearly and ensure comfort throughout the appointment.
Laboratory analysis uses state-of-the-art PCR equipment operated by experienced technicians who specialise in molecular diagnostics. Quality control procedures ensure accurate results and rapid turnaround times.
Results are communicated discreetly through secure channels, with clear explanations of findings and appropriate next steps. When infections are detected, we provide guidance on treatment options and partner notification considerations.
For comprehensive sexual health screening, our full STI screen includes PCR testing for multiple infections alongside traditional screening methods.
Complications of Undetected Mycoplasma Genitalium
Untreated Mycoplasma genitalium infections can lead to serious complications, particularly in women, making accurate detection crucial for preventing long-term health problems. Early identification through PCR testing helps prevent these complications from developing.
In women, untreated infections may progress to pelvic inflammatory disease (PID), which can cause chronic pelvic pain, fertility problems, and increased risk of ectopic pregnancy. These complications underscore the importance of reliable testing methods that can detect infections before serious damage occurs.
Men may develop epididymitis or prostatitis from untreated Mycoplasma genitalium infections, causing persistent pain and potentially affecting fertility. These complications can be prevented through timely diagnosis and appropriate treatment.
The asymptomatic nature of many Mycoplasma genitalium infections means that complications may be the first sign of infection, highlighting the value of testing following potential exposure even when symptoms are absent.
Frequently Asked Questions
Can other tests detect Mycoplasma genitalium reliably?
No, PCR testing is currently the only reliable method for detecting Mycoplasma genitalium. Traditional bacterial cultures and other standard tests lack the sensitivity needed for accurate detection.
How accurate is PCR testing for Mycoplasma genitalium?
PCR testing demonstrates over 95% sensitivity and 98% specificity for Mycoplasma genitalium detection, making it extremely reliable for both confirming infections and ruling them out.
Should I test if I have no symptoms?
Testing may be appropriate following potential exposure or if a partner has been diagnosed with Mycoplasma genitalium, as many infections are asymptomatic.
How soon after exposure can PCR testing detect infection?
PCR testing can typically detect Mycoplasma genitalium within 1-2 weeks of infection, though testing timing should be discussed based on individual circumstances.
Are Mycoplasma genitalium infections common?
Studies suggest Mycoplasma genitalium affects 1-4% of the general population, with higher rates among sexually active individuals and those with multiple partners.
Can symptoms appear and disappear?
Yes, Mycoplasma genitalium symptoms can be intermittent or mild, which may lead people to dismiss them as temporary irritation rather than infection.
When to Seek Medical Advice
Persistent urogenital symptoms warrant medical attention, particularly when they do not resolve with standard treatments or recur frequently. Severe pain, unusual discharge, or symptoms that worsen over time should prompt healthcare consultation.
If you have been diagnosed with other STIs or your partner has been diagnosed with Mycoplasma genitalium, medical advice regarding testing and treatment is important for preventing reinfection and complications.
If symptoms persist or worsen, consultation with an appropriate healthcare service may be advised, particularly when symptoms are severe or accompanied by fever, severe pain, or other concerning features.
Confidential STI Testing in the UK
If you are concerned about possible Mycoplasma genitalium exposure or are experiencing urogenital symptoms, confidential PCR testing appointments are available at our UK clinic. Testing decisions depend on symptoms, exposure history, and individual risk factors.
Our testing services include comprehensive chlamydia and gonorrhoea testing alongside Mycoplasma genitalium screening, providing thorough sexual health assessment when multiple infections may be present.
Results are provided discreetly with clear explanations and appropriate guidance for next steps when needed.
Disclaimer: This article is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Sexual health concerns should always be assessed in the context of individual circumstances, and if you are experiencing symptoms that are persistent, severe, or worsening, we recommend consulting an appropriate healthcare service. Please note that our clinic provides private STI testing services only.
Get Tested Today
Take control of your sexual health with our confidential, comprehensive STI testing services.
Share this article:
